Previous Close | 0.9100 |
Open | 0.5900 |
Bid | 0.1500 |
Ask | 1.7500 |
Strike | 185.00 |
Expire Date | 2024-06-21 |
Day's Range | 0.5900 - 0.5900 |
Contract Range | N/A |
Volume | |
Open Interest | 22 |
Hologic's (HOLX) GYN Surgical Q2 performance was driven by strong results from MyoSure and Fluent Fluid Management.
Lantheus' (LNTH) robust revenues from the majority of its segments drive its first-quarter performance.
Bruker's (BRKR) BioSpin segment witnessed growth across biopharma, academic government and industrial research in the first quarter of 2024.